← FDA Drug Approvals (Drugs@FDA)
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT · Approved 2025-08-11
Drug application
- FDA Application #
ANDA219692- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE
- Generic name
- Norepinephrine Bitartrate
- Active ingredients
- NOREPINEPHRINE BITARTRATE
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- SAGENT
- First approval
- 2025-08-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown